Humanigen Inc (HGENQ)
0.0002
-0.01
(-97.01%)
USD |
OTCM |
Apr 26, 16:00
Humanigen Total Liabilities (Quarterly): 54.84M for March 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2023 | 54.84M |
December 31, 2022 | 57.96M |
September 30, 2022 | 78.37M |
June 30, 2022 | 99.54M |
March 31, 2022 | 96.37M |
December 31, 2021 | 94.75M |
September 30, 2021 | 95.58M |
June 30, 2021 | 78.04M |
March 31, 2021 | 81.82M |
December 31, 2020 | 22.76M |
September 30, 2020 | 14.87M |
June 30, 2020 | 10.97M |
March 31, 2020 | 16.72M |
December 31, 2019 | 14.84M |
September 30, 2019 | 13.26M |
June 30, 2019 | 12.35M |
March 31, 2019 | 10.28M |
December 31, 2018 | 9.48M |
September 30, 2018 | 9.306M |
June 30, 2018 | 8.072M |
March 31, 2018 | 7.921M |
December 31, 2017 | 26.01M |
September 30, 2017 | 24.14M |
Date | Value |
---|---|
June 30, 2017 | 16.61M |
March 31, 2017 | 14.90M |
December 31, 2016 | 9.097M |
September 30, 2016 | 5.118M |
June 30, 2016 | 9.461M |
March 31, 2016 | 8.185M |
December 31, 2015 | 5.414M |
September 30, 2015 | 12.60M |
June 30, 2015 | 14.30M |
March 31, 2015 | 15.84M |
December 31, 2014 | 18.36M |
September 30, 2014 | 17.31M |
June 30, 2014 | 19.95M |
March 31, 2014 | 15.90M |
December 31, 2013 | 18.17M |
September 30, 2013 | 19.62M |
June 30, 2013 | 17.08M |
March 31, 2013 | 18.89M |
December 31, 2012 | 119.48M |
September 30, 2012 | 9.145M |
June 30, 2012 | 105.12M |
December 31, 2011 | 91.69M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
10.97M
Minimum
Jun 2020
99.54M
Maximum
Jun 2022
52.69M
Average
56.40M
Median
Total Liabilities (Quarterly) Benchmarks
Athersys Inc | 43.82M |
Merck & Co Inc | 69.04B |
MEI Pharma Inc | 19.05M |
ContraFect Corp | 14.88M |
Bristol-Myers Squibb Co | 82.48B |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 5.116M |
Shareholders Equity (Quarterly) | -49.72M |
Current Ratio | 0.0943 |
Net Debt Paydown Yield | 29.27% |